USA TODAY has reached out to the attorneys for comment. Philips announced a recall for millions of their Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP ...

The Food and Drug Administration has labeled a recall of Philips’ Tack Endovascular Systems as a Class l, which is the most serious kind of recall. There have been 20 reported injuries and no ...

Mass tort cases present unique challenges for both plaintiff’s and defense counsel. Unlike a class-action case, where a ...

Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...

There have been 147 medical device recall events and 20 of them, or 13.6%, were Class I. Philips recalled its remote cardiac monitoring software Dec. 18, and the FDA issued a notice Jan. 14 ...

Koninklijke Philips tackles challenges in China while focusing on AI and cost-cutting. Find out why PHG stock is a buy with promising EBITDA growth.

Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels following a serious product recall. The company’s Tack endovascular system includes a ...

Philips is recalling the Tack endovascular system because of what it says are user challenges that have led to additional interventions needed to retrieve or remove the implant. The US Food and Drug ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.